pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
RISING · news · pharmadog
← back to RISING
News mentioning RISING
91
stories
14h
AbbVie touts strong momentum for Skyrizi despite rising competition
endpoints
16h
STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals
stat
18h
STAT+: Up and down the ladder: The latest comings and goings
stat
19h
STAT+: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more
stat
1d
Syphilis spreads while researchers contend with federal constraints and a drug shortage
stat
1d
Judge denies states’ motion to postpone Medicaid work requirement
stat
1d
STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels
stat
1d
Ebola outbreak nears milestone, while a vaccine remains months away
stat
2d
NSF testing new Ph.D. model giving trainees academic and industry experience
stat
2d
STAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuit
stat
2d
STAT+: End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costs
stat
2d
2026 IPO stock tracker: How newly public biotechs are performing
biospace
3d
Eli Lilly tops new biopharma ranking on launch success, development speed
fiercebiotech
4d
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
5d
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
7d
STAT+: Up and down the ladder: The latest comings and goings
stat
7d
STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
stat
8d
Opinion: I may be one of the last middle-class medical students who could afford to become a doctor
stat
8d
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
fiercebiotech
9d
Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear
fiercebiotech
9d
6 companies hiring in Cambridge now
biospace
10d
Trump administration says it’s deferring $1B in Medicaid payments to California and Minnesota
stat
10d
STAT+: Rare disease drugmakers try to avoid Trump price cuts
stat
10d
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
biospace
10d
Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth
stat
10d
STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more
stat
10d
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
stat
11d
STAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and more
stat
12d
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
12d
STAT+: State audit of Medicaid records points to methods used by PBMs to obscure drug costs
stat
← prev
page 1 of 4
next →
